St. Jude Medical, Inc.  

(Public, NYSE:STJ)   Watch this stock  
Find more results for stj
65.93
-0.74 (-1.11%)
Real-time:   2:43PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 65.70 - 66.62
52 week 54.80 - 71.90
Open 66.34
Vol / Avg. 733,243.00/1.68M
Mkt cap 18.72B
P/E 19.06
Div/yield 0.29/1.76
EPS 3.46
Shares 280.12M
Beta 1.32
Inst. own 89%
May 7, 2015
St. Jude Medical Inc Annual Shareholders Meeting - 9:30AM EDT - Add to calendar
Apr 14, 2015
Q1 2015 St. Jude Medical Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Mar 11, 2015
St. Jude Medical Inc at Barclays Healthcare Conference
Feb 6, 2015
St. Jude Medical Inc Corporate Analyst Meeting
Jan 28, 2015
Q4 2014 St. Jude Medical Inc Earnings Release
Jan 28, 2015
Q4 2014 St. Jude Medical Inc Earnings Call
Jan 14, 2015
St. Jude Medical Inc at JPMorgan Healthcare Conference
Jan 14, 2015
Preliminary Q4 2014 St. Jude Medical Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Jan '15) 2015
Net profit margin 16.54% 16.99%
Operating margin 19.46% 20.47%
EBITD margin - 31.31%
Return on average assets 8.67% 9.34%
Return on average equity 22.00% 23.77%
Employees 16,000 -
CDP Score - -

Address

1 Saint Jude Medical Dr
SAINT PAUL, MN 55117-1789
United States - Map
+1-651-7562000 (Phone)
+1-651-7563301 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

St. Jude Medical, Inc., is a medical technology company. The Company is engaged in providing solutions for the treatment of epidemic diseases, including atrial fibrillation, heart failure, stroke, coronary artery disease, congenital heart defects, Parkinson�s disease and chronic pain. The Company�s provides medical solutions for Coronary Artery Disease, Heart Failure, Chronic Pain, Congenital Heart Defects, Heart Valve Disease, and Sudden Cardiac Arrest. Coronary Artery Disease, offers ILUMIEN system imaging platform. Heart Failure, offers Quadripolar Pacing, Thoracic Impedance Monitoring, and Left Atrial Pressure Monitoring. Chronic Pain, offers Spinal cord stimulation devices. Congenital Heart Defects, offers Ventricular Septal Defect Occlusion, Atrial Septal Defect Occlusion, and Patent Ductus Arteriosus Occlusion. Heart Valve Disease, offers Surgical Valve Replacement. Sudden Cardiac Arrest, offers Implantable Cardiac Defibrillation Therapy.

Officers and directors

Daniel J. Starks Chairman of the Board, President, Chief Executive Officer
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Donald J. Zurbay Chief Financial Officer, Vice President - Finance
Age: 47
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joel D. Becker President - Americas Division
Age: 47
Bio & Compensation  - Reuters
Eric S. Fain M.D. Group President - St. Jude Medical
Age: 54
Bio & Compensation  - Reuters
Denis M. Gestin President - International
Age: 51
Bio & Compensation  - Reuters
Michael T. Rousseau Chief Operating Officer
Age: 59
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
John C. Heinmiller Executive Vice President
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark W. Murphy Vice President - Information Technology, Chief Information Officer
Age: 46
Bio & Compensation  - Reuters
Lisa Malden Andrade Chief Marketing Officer, Vice President
Age: 43
Bio & Compensation  - Reuters
I. Paul Bae Chief Marketing Officer, Vice President - Global Human Resources
Age: 50
Bio & Compensation  - Reuters